ARCHIVES

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

Lenalidomide Maintenance Increased PFS and Survival

May 25, 2012

DCT Board Approves $8 Million In Contract Projects For Recompetition

October 31, 1980

PET Better At Evaluating Response In Sarcoma

February 29, 2008

In Brief: Harkin Proposes To Add Another $400 Million To NCU Budget, Money To Come Forom Defense

July 26, 1991

Cornel Student Withdraws In Wake Of Discrepancies Found In Study

September 18, 1981

Bush Appoints Andrew von Eschenback, Of M. D. Anderson, As 12th NCI Director.

December 7, 2001